Cargando…

Prognostic scales in advanced heart failure

Heart transplantation (HT) is the treatment of choice for patients with advanced heart failure (HF) who remain symptomatic despite optimal medical therapy. Due to the shortage of organs for transplantation and constantly increasing number of patients placed on waiting lists, accurate risk stratifica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szczurek, Wioletta, Szyguła-Jurkiewicz, Bożena, Siedlecki, Łukasz, Gąsior, Mariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2018
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180023/ https://www.ncbi.nlm.nih.gov/pubmed/30310398 http://dx.doi.org/10.5114/kitp.2018.78444

Ejemplares similares

Clinical features, management and mortality in diabetic and non-diabetic patients with heart failure – observations from the COMMIT-HF registry
por: Siedlecki, Łukasz, et al.
Publicado: (2017)

Apelin Improves Prognostic Value of HFSS (Heart Failure Survival Score) and MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) Scales in Ambulatory Patients with End-Stage Heart Failure †
por: Szczurek, Wioletta, et al.
Publicado: (2020)

The Utility of Pentraxin and Modified Prognostic Scales in Predicting Outcomes of Patients with End-Stage Heart Failure
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Obesity in patients with end-stage heart failure
por: Król, Bogumiła, et al.
Publicado: (2018)

Factors Associated with Ineffectiveness of Sildenafil Treatment in Patients with End-Stage Heart Failure and Elevated Pulmonary Vascular Resistance
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Mechanical circulatory support in heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2016)

Oxidative stress and inflammatory markers – the future of heart failure diagnostics?
por: Szczurek, Wioletta, et al.
Publicado: (2015)

Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

The role of statins in chronic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Factors associated with cardiac allograft vasculopathy after heart transplantation
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Investigation of the Role of Oxidative Stress and Factors Associated with Cardiac Allograft Vasculopathy in Patients after Heart Transplantation
por: Szczurek, Wioletta, et al.
Publicado: (2020)

The role of statins in patients after heart transplantation
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Oxidative Stress Markers and Modified Model for End-Stage Liver Disease Are Associated with Outcomes in Patients with Advanced Heart Failure Receiving Bridged Therapy with Continuous-Flow Left Ventricular Assist Devices
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2021)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021)

Everolimus-Eluting Second-Generation Stents for Treatment of De Novo Lesions in Patients with Cardiac Allograft Vasculopathy
por: Pyka, Łukasz, et al.
Publicado: (2020)

The role of optical coherence tomography and other intravascular imaging modalities in cardiac allograft vasculopathy
por: Dyrbuś, Maciej, et al.
Publicado: (2020)

The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Oxidative Stress Markers in Hypertrophic Cardiomyopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2021)

Five-year survival of patients with chronic systolic heart failure of ischemic and non-ischemic etiology: analysis of prognostic factors
por: Mościński, Mateusz, et al.
Publicado: (2014)

The Impact of Short-Term Outdoor Air Pollution on Clinical Status and Prognosis of Hospitalized Patients with Coronary Artery Disease Treated with Percutaneous Coronary Intervention
por: Desperak, Piotr, et al.
Publicado: (2022)

Depression is the strongest predictor of long-term outcome in patients with chronic nonischemic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Low health-related quality of life is a predictor of major adverse cardiovascular events in patients with chronic nonischemic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Revascularization in ischemic heart failure with reduced left ventricular ejection fraction. The impact of complete revascularization
por: Pyka, Łukasz, et al.
Publicado: (2017)

Comparison of coronary artery bypass grafting and percutaneous coronary intervention in patients with heart failure with reduced ejection fraction and multivessel coronary artery disease
por: Hawranek, Michał, et al.
Publicado: (2018)

The association of functional polymorphisms in genes encoding growth factors for endothelial cells and smooth muscle cells with the severity of coronary artery disease
por: Osadnik, Tadeusz, et al.
Publicado: (2016)

The relationship between late gadolinium enhancement imaging and myocardial biopsy in the evaluation of chronic heart failure patients with suspected myocarditis
por: Nowak, Jolanta, et al.
Publicado: (2014)

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
por: Gąsior, Paweł, et al.
Publicado: (2018)

Clinical and laboratory determinants of low serum level of 25-hydroxyvitamin D during escalation of pharmacotherapy in heart failure patients
por: Myrda, Krzysztof, et al.
Publicado: (2015)

Sodium-Glucose Cotransporter-2 Inhibitors-from the Treatment of Diabetes to Therapy of Chronic Heart Failure
por: Kurczyński, Dominik, et al.
Publicado: (2022)

Ceruloplasmin as Redox Marker Related to Heart Failure Severity
por: Lazar-Poloczek, Elżbieta, et al.
Publicado: (2021)

Novel device-based interventional strategies for advanced heart failure
por: Toth, Gabor G., et al.
Publicado: (2016)

Inter-Rater Reliability of the Polish Version of the Alberta Infant Motor Scale in Children with Heart Disease
por: Ferenstein, Maria, et al.
Publicado: (2023)

Death without Previous Hospital Readmission in Patients with Heart Failure with Reduced Ejection Fraction—A New Endpoint from Old Clinical Trials
por: Niedziela, Jacek T., et al.
Publicado: (2022)

Interaction Between Heart Rate Variability and Heart Rate in Pediatric Population
por: Gąsior, Jakub S., et al.
Publicado: (2015)

Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Advanced and Acute Heart Failure
por: Hyun, Junho, et al.
Publicado: (2023)

Outcomes of COVID-19 in heart failure, LVAD, and heart transplant patients in an advanced heart failure practice
por: George, Susan, et al.
Publicado: (2022)

Advances in systolic heart failure
por: Yuzefpolskaya, Melana, et al.
Publicado: (2010)

Recent advances in treatment of heart failure
por: Kitai, Takeshi, et al.
Publicado: (2015)

Cardiac Surgery in Advanced Heart Failure
por: Hullin, Roger, et al.
Publicado: (2022)

Mechanical circulatory support in cardiogenic shock – what every interventional cardiologist should know
por: Pyka, Łukasz, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l1frtajh3ls5av7potjt1vvnti